Mylin Torres, MD, is a board-certified radiation oncologist who specialises in the treatment of breast cancer.

Dr Torres is a Professor and serves as the Vice Chair of Academic Operations and the Director of the Division of Health Services Research, Outcomes, and Policy in the Department of Radiation Oncology at Emory University School of Medicine. Dr Torres also co-leads the Cancer Prevention and Control research program at the Winship Cancer Institute of Emory University, where she coordinates and promotes all cancer prevention and control-related research activities. She previously served as the Director of the Glenn Family Breast Center.

Her research program is dedicated to understanding the biology underlying treatment-related side effects, including chronic inflammation, radiation-induced skin changes, and cancer-related fatigue, and to developing interventions that will improve the life quality of breast cancer survivors. She is also examining ways that radiation can be used to help women with metastatic disease.

Dr Torres has written and co-authored a number of publications and abstracts. She has received highly competitive grants from the National Cancer Institute, Radiation Therapy Oncology Group (now NRG Oncology), Winship Cancer Institute, and Susan G. Komen to support her research on the detection and treatment of breast cancer therapy-induced toxicities.

For her outstanding care of patients, Dr Torres was awarded the Atlanta Business Chronicle’s Healthcare Heroes Rising Star, the Winship Cancer Institute Above and Beyond Award, and the Winship Annual Mentorship Award. Atlanta Magazine also named her as one of the “Women Making a Mark” in the Atlanta community. She currently serves on the Advisory Committee on Breast Cancer in Young Women of the Centers for Disease Control and Prevention.

Dr Torres graduated magna cum laude from Harvard University with a bachelor’s degree in biology. She then went on to receive her medical degree from Stanford University before completing her training in radiation oncology at The University of Texas MD Anderson Cancer Center.